Development of a predictive model for major adverse cardiac events in a coronary artery bypass and valve population

Table 3 Frequency of MACE and MACE components in the model development cohort

Variable		All Procedures	CABG	AVR/MVR/MVrpr	CABG + Valve
		n=4270	n=3095	n=696	n=479
		(%)	(%)	(%)	(%)
MACE*		15.7	13.0	14.0	32.0
Mortality		4.2	3.3	3.3	11.5
Acute renal failure		6.5	5.5	5.5	14.0
Any stroke		2.9	2.3	2.4	7.3
	Transient (<24 h)	1.7	0.9	1.2	3.1
	Permanent	1.7	1.4	1.3	4.2
Infection		8.0	7.1	6.3	16.1
	Deep sternal Wound infection	1.1	1.0	0.1	2.9
	Sepsis	2.8	2.4	1.9	7.3
	Pneumonia	6.5	5.7	5.3	13.6

*MACE—Major Adverse Cardiac Event defined as in-hospital death, stroke (persisting at discharge or transient), acute renal failure (new post-operative renal failure or acute on chronic (>50% increase from baseline creatinine)), or infection (sepsis, pneumonia, or deep sternal wound infection).

ISSN: 1749-8090